TSI’s first product the Trans-Insulin™ patch is now in phase-3 clinical trials. Our formulation experts, analytical chemists, and clinical and regulatory specialists are leaders in both science and drug development
TSI’s first product the Trans-Insulin™ patch is now in phase-3 clinical trials. Our formulation experts, analytical chemists, and clinical and regulatory specialists are leaders in both science and drug development